Accolade Inc (FRA:4NE1)
€ 3.16 0.04 (1.28%) Market Cap: 266.40 Mil Enterprise Value: 270.67 Mil PE Ratio: 0 PB Ratio: 0.65 GF Score: 61/100

Accolade Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 13, 2022 / 02:35PM GMT
Release Date Price: €11.2 (-0.88%)
Craig Matthew Hettenbach
Morgan Stanley, Research Division - VP

Great. Well, good morning, everyone. Welcome to the 20th Annual Healthcare Conference. Glad to see a lot of faces in person. We're very pleased to host Accolade today, CEO, Raj Singh; and CFO, Steve Barnes. So welcome.

Rajeev Singh
Accolade, Inc. - Chairman of the Board & CEO

Thank you, Craig. Glad to be here.

Craig Matthew Hettenbach
Morgan Stanley, Research Division - VP

So I'm Craig Hettenbach. I focus on the health care technology within the Morgan Stanley services team. Just a quick disclosure before we start. You can see the disclosures at the Morgan Stanley research, www.morganstanley.com\researchdisclosures.

Questions & Answers

Craig Matthew Hettenbach
Morgan Stanley, Research Division - VP

So with that out of the way, I wanted to start with the macro just because it's top of mind for investors. And certainly, if I look back a year ago, tight labor market. You fast

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot